IR LIBRARY News & Press Releases 02/10 IR Notice regarding Earnings Forecast 01/26 IR (Progress of Matters Previously Disclosed) Status of Discussions Toward Execution of a License Agreement with Laboratoires KÔL regarding Emixustat Hydrochloride, a Treatment Candidate for Stargardt Disease, at a Consolidated Subsidiary, Kubota Vision Inc. 01/21 IR Notice regarding the Waiver of Executive Compensation by the Chairman, President & CEO 12/22 IR (Update on Disclosure Matters) Status of Discussions Toward Execution of a License Agreement with Laboratoires KÔL regarding Emixustat Hydrochloride, a Treatment Candidate for Stargardt Disease, at a Consolidated Subsidiary, Kubota Vision Inc. more info For information on SEC filings, please visit U.S. SEC's EDGAR service. CEO Message Company Financials SEC Filings Shareholders Meeting IR News Corporate Governance Financial Events Calendar FAQs Email Alerts
